Cite

HARVARD Citation

    Kenmotsu, H. et al. (2022). Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010). Cancer science. 113 (12), pp. 4327-4338. [Online]. 
  
Back to record